Alt
/content/dam/genesiscare/headshots/uk-doctor-headshots/UK_Haematology_Headshot_GA_Dr Karthik Ramasamy.jpg
doctify
ramasamy
https://widgets.doctify.com/get-script?widget_container_id=ramasamy&type=horizontal-widget&tenant=athena-uk&language=en&profileType=specialist&layoutType=layoutA&slug=dr-karthik-ramasamy-1&background=transparent

Professor Karthik Ramasamy

Professor Karthik Ramasamy
Karthik
Ramasamy
MBBS, PhD, FRCP, FRCPath,
Consultant Haematologist

Languages spoken

English

Expert in

Haemato-oncology, Myeloma, MGUS, Smouldering myeloma and Amyloidosis, Bone marrow transplantation, Systemic anticancer therapy, CAR T cell therapy, Stem cell transplantation

Overview

Centres

Oxford
Oxford
Peters Way, Sandy Lane West, Oxford, Oxfordshire, OX4 6LB, England, UK
51.7239071200697, -1.2145938932540707
/uk/our-centres/oxford
Oxfordshire

About Professor Ramasamy

Professor Karthik Ramasamy undertook his general medical training at Nottingham University Hospitals NHS Trust (NUH) followed by early haematology training at NHS Greater Glasgow and Clyde (NHSGGC). He subsequently moved to London in 2002 and undertook a comprehensive haematology-training programme encompassing all subspecialties of haematology, including bone marrow transplantation and a PhD in myeloma studies at Kings College London (KCL). Professor Ramasamy now works at Oxford University Hospital NHS Trust and is Clinical Director of the Oxford Translational Myeloma Centre. Professor Ramasamy is a Member of UK Myeloma Society and ambassador of Myeloma UK, a patient charity. Professor Ramasamy is a Chief Investigator of UK multicentre myeloma trials and has published more than 150 peer-reviewed articles and written chapters in haemato oncology textbooks. Professor Ramasamy is also the Research Lead for Cancer and Haematology at Oxford University Hospitals.

Dr Karthik consults at our centre in Oxford, & also the Oxford University Hospitals NHS Foundation Trust

Plasma cell disorders such as MGUS, Smouldering myeloma and myeloma are potentially preventable or curable within the next 5-10 years. With the potential for early diagnosis, early intervention, application of novel diagnostics and cutting-edge systemic therapies including cell therapies, people diagnosed with these conditions can lead meaningful lives

Private cancer treatment

Professor Ramasamy welcomes patients for cancer treatment, for recurrence of cancer, or for a second opinion. Patients can self-refer and do not need a GP or hospital specialist referral.

Meet Professor Karthik Ramasamy, Haematologist

Career positions

Current position(s)

  • Consultant Haematologist, Oxford University Hospitals NHS Trust

Previous position(s)

Published research

Published research

Read about Professor Ramasamy's research here

Expertise and interests

Expertise

  • Chemotherapy
  • Blood transfusion
  • Stem cell transplantation

Interests

  • Haemato-oncology
  • Myeloma

Professional association

  • Fellow of the Royal College of Physicians (FRCP)
  • Fellow of the Royal College of Pathologists (FRCPath)
  • International Myeloma Working Group
  • UK Myeloma Research Alliance, Executive Member
  • UK Myeloma Society Member
  • UK Myeloma Forum Member
  • American Society for Haematology
  • British Society of Haematology
  • British Society of Bone and Marrow Transplantation

Dr Karthik Ramasamy reviews